Short answer
Edgewise Therapeutics, Inc. (EWTX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Item 2.02 signals Edgewise Therapeutics (EWTX) is reporting earnings results; full details are in the referenced press release exhibit.
Edgewise Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 signals Edgewise Therapeutics (EWTX) is reporting earnings results; full details are in the referenced press release exhibit
- Actual revenue, net loss, cash position, and clinical-stage pipeline cost data will be in the accompanying exhibit (typically Ex. 99.1)
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Edgewise Therapeutics, Inc. 8-K filings
Get the next EWTX 8-K as it lands
Follow EWTX for push alerts, or ask the research agent what this filing means.